抗人肺癌：其机制综述（综述）

An Qingwen, Wu Mengting, Yang Chuqi, Feng Yewen, Xu Xuefei, Su Hang, Zhang Guangji

School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.

Key Laboratory of Blood-Stasis-Toxin Syndrome of Zhejiang Province, Hangzhou, Zhejiang 310053, P.R. China.

Exp Ther Med. 2023 Feb 13;25(3):139. doi: 10.3892/etm.2023.11838. eCollection 2023 Mar.

Lung cancer is one of the commonest malignant tumors in the world today, causing millions of mortalities every year. New methods to treat lung cancer are urgently needed. Bunge is a common Chinese medicine, often used for promoting blood circulation. In the past 20 years, has made significant progress in the treatment of lung cancer and is considered to be one of the most promising methods to fight against the disease. A great amount of research has shown that the mechanism of against human lung cancer mainly includes inhibiting the proliferation of lung cancer cells, promoting lung cancer cell apoptosis, inducing cell autophagy, regulating immunity and resisting angiogenesis. Research has shown that has certain effects on the resistance to chemotherapy drugs. The present review discussed the status and prospects of against human lung cancer.

肺癌是当今世界上最常见的恶性肿瘤之一，每年导致数百万人死亡。迫切需要治疗肺癌的新方法。是一种常见的中药，常用于促进血液循环。在过去20年里，在肺癌治疗方面取得了显著进展，被认为是对抗该疾病最有前景的方法之一。大量研究表明，对抗人类肺癌的机制主要包括抑制肺癌细胞增殖、促进肺癌细胞凋亡、诱导细胞自噬、调节免疫和抵抗血管生成。研究表明，对化疗药物耐药性有一定作用。本综述讨论了对抗人类肺癌的现状和前景。

需注意，原文中“Bunge”处有缺失内容，翻译时按原文呈现了。